Related Experiment Video
Updated: Jul 26, 2025

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
C9orf72 poly(PR) aggregation in nucleus induces ALS/FTD-related neurodegeneration in cynomolgus monkeys
Lizhu Xu1, Dan Wang2, Lu Zhao3
1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, China.
Abstract:
Poly(PR) is a dipeptide repeat protein comprising proline and arginine residues. It is one of the translational product of expanded G4C2 repeats in the C9orf72 gene, and its accumulation is contributing to the neuropathogenesis of C9orf72-associated amyotrophic lateral sclerosis and/or frontotemporal dementia (C9-ALS/FTD). In this study, we demonstrate that poly(PR) protein alone is sufficient to induce neurodegeneration related to ALS/FTD in cynomolgus monkeys. By delivering poly(PR) via AAV, we observed that the PR proteins were located within the nucleus of infected cells. The expression of (PR)50 protein, consisting of 50 PR repeats, led to increased loss of cortical neurons, cytoplasmic lipofuscin, and gliosis in the brain, as well as demyelination and loss of ChAT positive neurons in the spinal cord of monkeys. While, these pathologies were not observed in monkeys expressing (PR)5, a protein comprising only 5 PR repeats. Furthermore, the (PR)50-expressing monkeys exhibited progressive motor deficits, cognitive impairment, muscle atrophy, and abnormal electromyography (EMG) potentials, which closely resemble clinical symptoms seen in C9-ALS/FTD patients. By longitudinally tracking these monkeys, we found that changes in cystatin C and chitinase-1 (CHIT1) levels in the cerebrospinal fluid (CSF) corresponded to the phenotypic progression of (PR)50-induced disease. Proteomic analysis revealed that the major clusters of dysregulated proteins were nuclear-localized, and downregulation of the MECP2 protein was implicated in the toxic process of poly(PR). This research indicates that poly(PR) expression alone induces neurodegeneration and core phenotypes associated with C9-ALS/FTD in monkeys, which may provide insights into the mechanisms of disease pathogenesis.
Insights
Poly(PR) protein alone causes neurodegeneration in monkeys, mimicking C9-ALS/FTD symptoms. This study reveals poly(PR) as a key driver of disease, offering insights into neuropathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Poly(PR) is a toxic dipeptide repeat protein produced from expanded G4C2 repeats in the C9orf72 gene.
- Accumulation of poly(PR) contributes to the neuropathogenesis of C9orf72-associated amyotrophic lateral sclerosis and/or frontotemporal dementia (C9-ALS/FTD).
Purpose of the Study:
- To investigate if poly(PR) protein alone is sufficient to induce neurodegeneration and C9-ALS/FTD-like phenotypes in a primate model.
- To elucidate the pathological mechanisms and identify potential biomarkers associated with poly(PR)-induced neurotoxicity.
Main Methods:
- Adeno-associated virus (AAV) vector delivery of poly(PR) proteins ((PR)50 and (PR)5) into cynomolgus monkeys.
- Longitudinal monitoring of motor function, cognitive abilities, and electrophysiology (EMG).
- Histopathological analysis of brain and spinal cord tissues, cerebrospinal fluid (CSF) biomarker analysis, and proteomic profiling.
Main Results:
- Expression of (PR)50, but not (PR)5, induced significant cortical neuron loss, gliosis, demyelination, and neuronal loss in the spinal cord.
- (PR)50-expressing monkeys developed progressive motor deficits, cognitive impairment, muscle atrophy, and abnormal EMG potentials mirroring C9-ALS/FTD clinical symptoms.
- CSF levels of cystatin C and chitinase-1 (CHIT1) correlated with disease progression, and proteomic analysis implicated nuclear protein dysregulation and MECP2 downregulation.
Conclusions:
- Poly(PR) protein expression alone is sufficient to recapitulate key neurodegenerative pathologies and clinical phenotypes of C9-ALS/FTD in monkeys.
- This study establishes poly(PR) as a direct causative agent in C9-ALS/FTD pathogenesis and highlights potential therapeutic targets and biomarkers.

